Alnylam Act - No Charge, Third Party Genetic Testing & Counseling

June 27, 2019

Learn about Alnylam Act, Alnylam’s no charge, third party genetic testing and counseling service for individuals who may carry gene mutations known to be associated with either hereditary ATTR (hATTR) amyloidosis, acute hepatic porphyria (AHP), or primary hyperoxaluria type 1 (PH1). Get more information at AlnylamAct.com.

Spotlight

Pharmacy Alliance

With the combined strength of more than 650 members and an expert team, Pharmacy Alliance has developed a network of industry partnerships to simplify operating a pharmacy. Our aims are to help make our be more profitable, be competitive and feel like royalty.

OTHER VIDEOS

The Future of Pharmacy Management Software

video | November 17, 2022

Welcome to the future of pharmacy management software! Axys is built from the ground up on the most modern technology. Not the most modern technology in long-term care....

Watch Now

How advanced simulation accelerates new technology development

video | November 22, 2022

PureBlue Water and AM-Team work together in this European CrossRoads2 Sustainable Energy project to develop a novel technology to remove pharmaceutical residues from wastewater....

Watch Now

Smart Quality Is The Future Of Quality Management

video | November 23, 2022

Smart Quality is a term that describes a new way of thinking about quality control and improvement. It emphasizes using data and technology to drive value and improve performance....

Watch Now

Bravado Pharmaceuticals - Hei-VAP Rotary Evaporator

video | November 16, 2022

Bravado Pharmaceuticals is a state-of-the-art, innovative pharmaceutical contract development organization....

Watch Now

Spotlight

Pharmacy Alliance

With the combined strength of more than 650 members and an expert team, Pharmacy Alliance has developed a network of industry partnerships to simplify operating a pharmacy. Our aims are to help make our be more profitable, be competitive and feel like royalty.

Events